Sale!

TELAML1 Quantitative Test Cost

Original price was: 1,600 د.إ.Current price is: 1,200 د.إ.

-25%

The TELAML1 Quantitative Test is a specialized diagnostic procedure designed to detect and measure the presence of the TEL-AML1 fusion gene, which is often associated with certain types of leukemia, particularly Acute Lymphoblastic Leukemia (ALL). This genetic abnormality results from the translocation between chromosomes 12 and 21, and its identification is crucial for the accurate diagnosis, prognosis, and treatment planning for patients affected by this condition.

Performed at DNA Labs UAE, a leading facility in genetic testing, the TELAML1 Quantitative Test employs advanced molecular techniques to ensure precise and reliable results. The test is particularly valuable for monitoring disease progression or response to therapy in patients diagnosed with leukemia.

The cost of the TELAML1 Quantitative Test at DNA Labs UAE is 1200 AED. This investment is essential for those needing detailed genetic insights into their leukemia diagnosis, allowing for tailored treatment approaches and better management of the disease.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TELAML1 Quantitative Test Cost AED:1200.0 – Symptoms, Diagnosis, and More

Are you concerned about T-cell acute lymphoblastic leukemia (T-ALL)? DNA Labs UAE offers the TELAML1 Quantitative Test at a cost of AED 1200.0. This test is a crucial tool for the diagnosis and management of T-ALL patients.

Test Name: TELAML1 Quantitative Test

  • Components: EDTA Vacutainer (2ml)
  • Price: 1200.0 AED
  • Sample Condition: Bone marrow / Peripheral blood (Transport immediately)
  • Report Delivery: 3-4 days
  • Method: Real Time PCR
  • Test Type: Genetics
  • Doctor: General Physician
  • Test Department:

Pre Test Information

TEL/AML1 Quantitative Test requires a doctor’s prescription. However, please note that the prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

TEL/AML1 is a fusion gene associated with T-cell acute lymphoblastic leukemia (T-ALL). It is formed due to a chromosomal translocation between the TEL (ETV6) gene on chromosome 12 and the AML1 (RUNX1) gene on chromosome 21. The TEL/AML1 Quantitative Test measures the levels of the fusion transcript in patient samples using techniques such as real-time polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH).

Quantification of TEL/AML1 transcripts is crucial for several reasons. Firstly, it aids in the diagnosis of T-ALL as the presence of the fusion gene is a characteristic feature of this subtype. Secondly, it helps monitor the response to treatment, as a decrease in the levels of the fusion transcript indicates a favorable response. Lastly, it can detect minimal residual disease (MRD), which refers to a small number of leukemia cells that may remain in the body after treatment and can potentially lead to relapse.

By analyzing TEL/AML1 quantitatively, valuable information for the management of T-ALL patients can be obtained. This includes early detection of relapse and adjustment of treatment strategies.

Don’t wait! Get your TELAML1 Quantitative Test done at DNA Labs UAE today.

Test Name TELAML1 Quantitative Test
Components EDTA Vacutainer (2ml)
Price 1200.0 AED
Sample Condition Bone marrow \/ Peripheral blood (Transport immediately)
Report Delivery 3-4 days
Method Real Time PCR
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information TEL/AML1 Quantitative can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

TEL/AML1 is a fusion gene that is associated with a specific subtype of acute lymphoblastic leukemia (ALL) called T-cell acute lymphoblastic leukemia (T-ALL). It is formed as a result of a chromosomal translocation between the TEL (ETV6) gene on chromosome 12 and the AML1 (RUNX1) gene on chromosome 21.

Quantitative analysis of the TEL/AML1 fusion gene involves measuring the levels of the fusion transcript in patient samples. This can be done using techniques such as real-time polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH).

The quantification of TEL/AML1 transcripts is important for several reasons. Firstly, it helps in the diagnosis of T-ALL, as the presence of the fusion gene is a characteristic feature of this subtype. Secondly, it can be used to monitor the response to treatment, as a decrease in the levels of the fusion transcript indicates a favorable response. Lastly, it can be used to detect minimal residual disease (MRD), which refers to the small number of leukemia cells that may remain in the body after treatment and can potentially lead to relapse.

Quantitative analysis of TEL/AML1 can provide valuable information for the management of T-ALL patients, allowing for early detection of relapse and adjustment of treatment strategies.